Cluster Headache

Emgality sBLA Gets Priority Review for Preventive Treatment of Episodic Cluster Headache

Diana Ernst, RPh

March 8, 2019

The supplemental New Drug Application (sNDA) for Emgality (galcanezumab-gnlm; Lilly) has been granted Priority Review by the Food and Drug Administration (FDA) for the preventive treatment of episodic cluster headache in adults.

Migraine and Headache

SPG Stimulation Reduces Cluster Headache Pain, Frequency

Alicia Ciccone Editor

June 28, 2016

SPG stimulation is delivered on-demand through an implanted neurostimulator.

Migraine and Headache

Targeted Intranasal Ganglion Block May Ease Migraine Pain

March 2, 2015

The therapy effects lasted for about a month, as researchers noted the procedure would need to be repeated for continuous relief.

Migraine and Headache

Vagus Nerve Stimulation Helps Treat, Prevent Cluster Headache

February 26, 2015

The noninvasive device not only stopped acute attacks, but reduced overall headache frequency.

Next post in Migraine and Headache

Cluster Headache

Emgality sBLA Gets Priority Review for Preventive Treatment of Episodic Cluster Headache

SPG Stimulation Reduces Cluster Headache Pain, Frequency

Targeted Intranasal Ganglion Block May Ease Migraine Pain

Vagus Nerve Stimulation Helps Treat, Prevent Cluster Headache

Inhibition of Trigeminal Nociception May Be Impaired in Migraine